Skip to content

Effect of preoperative transaural vagus nerve stimulation on postoperative delirium in cancer patients receiving preoperative chemotherapy

Effect of preoperative transaural vagus nerve stimulation on postoperative delirium in cancer patients receiving preoperative chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091586
Enrollment
Unknown
Registered
2024-10-30
Start date
2024-11-01
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium

Interventions

Electrical stimulation group:Patients in the experimental group received transaural vagus nerve electrical stimulation therapy two weeks before surgery, using the optimal stimulation parameters (stimu

Sponsors

Jiangsu Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Tumor patients who are expected to undergo surgery for ovarian cancer, breast cancer, esophageal cancer, and lung cancer should receive 2 or more cycles of chemotherapy combined with paclitaxel and platinum-based drugs before surgery, and undergo elective tumor resection 4 weeks after the completion of preliminary chemotherapy; 2.ASA classification: II-III; 3.18.5kg/m2<BMI<30kg/m2; 4.Age 18-65 years old.

Exclusion criteria

Exclusion criteria: 1.Patients with a history of craniocerebral trauma, severe neurological and psychiatric diseases, and language communication disorders; 2.Patients with damaged ear skin; 3.Patients with sinus bradycardia; 4. A history of severe asthma; 5.Patients with other malignant tumors.

Design outcomes

Primary

MeasureTime frame
Delirium incidence 7 days after surgery;

Secondary

MeasureTime frame
Incidence of subdelirium syndrome 7 days after surgery;Postoperative pain;TNF-a level in peripheral blood;IL-6;IL-8;

Countries

China

Contacts

Public ContactJianhua He

Jiangsu Cancer Hospital

hejianhua_73@163.com+86 137 7070 1804

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026